SCHEMBL7670833

SCHEMBL7670833

C/[C]=C/C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27272056 1.00
SCHEMBL7670830 1.00
SCHEMBL1660 0.71
SCHEMBL1659 0.71
SCHEMBL4718654 0.69
SCHEMBL6578754 0.69
SCHEMBL11451075 0.69
Methyl Alcohol SCHEMBL27686327 0.69
SCHEMBL6578757 0.69
SCHEMBL8879663 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5561228-A IMMUNOSUPPRESSNATS; SIDE EFFECT REDUCTION ABBOTT LABORATORIES (US) 1996-10-01 US claimed
EP-0330017-A2 Use of thiazoles for increasing animal performance BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) 1989-08-30 EP claimed
US-6455697-B2 Substituted phenyluracils BAYER AKTIENGESELLSCHAFT (DE) 2002-09-24 US disclosed
EP-0843667-B1 SUBSTITUTED PHENYLURACILS BAYER AG (DE) 2001-10-17 EP disclosed
US-6251828-B1 HERBICIDE FOR TOTAL CONTROL OF WEEDS BAYER AKTIENGESELLSCHAFT (DE) 2001-06-26 US disclosed
US-20010003732-A1 1-(4-cyano-2-fluoro-5-(2-chloro-2-methoxycarbonylethyl) -phenyl)-3,6-dihydro-2,6-dioxo-3-methyl-4-trifluoromethyl-1-(2H)-pyrimidine, for example; use as herbicides; chemical intermediates and method of synthesis ANDREE ROLAND (DE) 2001-06-14 US disclosed
EP-0843667-A1 SUBSTITUTED PHENYLURACILS BAYER AG (DE) 1998-05-27 EP disclosed
US-5604225-A DIETETICS; OBESITY DR. KARL THOMAE GMBH (DE) 1997-02-18 US disclosed
WO-1997005118-A1 SUBSTITUTED PHENYLURACILS BAYER AKTIENGESELLSCHAFT (DE) 1997-02-13 WO disclosed
US-5561228-A IMMUNOSUPPRESSNATS; SIDE EFFECT REDUCTION ABBOTT LABORATORIES (US) 1996-10-01 US disclosed
US-5457205-A Substituted thiazoles useful for treatment of diabetes DR. KARL THOMAE GMBH (DE) 1995-10-10 US disclosed
EP-0334146-A1 Morpholines and morpholine-N-oxides, medicines containing these compounds and process for their preparation Dr. Karl Thomae GmbH (DE) 1989-09-27 EP disclosed
US-4870076-A ANTICOAGULANTS KARL THOMAE GMBH (DE) 1989-09-26 US disclosed
EP-0330017-A2 Use of thiazoles for increasing animal performance BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) 1989-08-30 EP disclosed
EP-0330017-A2 Use of thiazoles for increasing animal performance BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) 1989-08-30 EP disclosed
US-4820705-A ANTITUMOR, CARDIOVASCULR DISORDERS DR. KARL THOMAE GMBH (DE) 1989-04-11 US disclosed
EP-0262395-A2 Sulfonamido-ethyl compounds, medicines containing them and process for their preparation Dr. Karl Thomae GmbH (DE) 1988-04-06 EP disclosed
EP-0253321-A2 Benzenesulfonamido-indanyl-compounds, medicines containing these compounds and process for their preparation Dr. Karl Thomae GmbH (DE) 1988-01-20 EP disclosed
EP-0203832-A1 13-Halomilbemycin derivatives, their preparation and compositions containing them SANKYO COMPANY LIMITED (JP) 1986-12-03 EP disclosed
EP-0190900-A2 Cephalosporin compounds, their production, and pharmaceutical compositions containing them YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1986-08-13 EP disclosed